Literature DB >> 34552680

Prescribing drugs to overweight and obese children: Balancing efficacy and safety.

Helene Roy1, Christel Bertoldi1, Catherine Farrell1, Elisabeth Rousseau1.   

Abstract

Entities:  

Year:  2021        PMID： 34552680      PMCID： PMC8448492          DOI： 10.1093/pch/pxaa108

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  24 in total

Review 1.  Improving paediatric medications: A prescription for Canadian children and youth.

Authors:  Charlotte Moore Hepburn; Andrea Gilpin; Julie Autmizguine; Avram Denburg; L Lee Dupuis; Yaron Finkelstein; Emily Gruenwoldt; Shinya Ito; Geert 't Jong; Thierry Lacaze-Masmonteil; Deborah Levy; Stuart Macleod; Steven P Miller; Martin Offringa; Maury Pinsk; Barry Power; Michael Rieder; Catherine Litalien
Journal:  Paediatr Child Health       Date:  2019-07-25       Impact factor: 2.253

2.  An aid to drug dosing safety in obese children: development of a new nomogram and comparison with existing methods for estimation of ideal body weight and lean body mass.

Authors:  L C Callaghan; J D Walker
Journal:  Anaesthesia       Date:  2014-10-07       Impact factor: 6.955

3.  Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.

Authors:  Emma L Ross; Justin Heizer; Mark A Mixon; Jennifer Jorgensen; Connie A Valdez; Angela S Czaja; Pamela D Reiter
Journal:  Am J Health Syst Pharm       Date:  2015-04-01       Impact factor: 2.637

Review 4.  Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children.

Authors:  Kathryn E Kyler; Jonathan Wagner; Chelsea Hosey-Cojocari; Kevin Watt; Valentina Shakhnovich
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

5.  Prescribing in obese children: how good are paediatricians?

Authors:  Helen Collier; Maria Nasim; Anjum Gandhi
Journal:  Arch Dis Child       Date:  2016-07-26       Impact factor: 3.791

Review 6.  What is the best size predictor for dose in the obese child?

Authors:  Brian J Anderson; Nick Hg Holford
Journal:  Paediatr Anaesth       Date:  2017-10-26       Impact factor: 2.556

7.  Characteristics and Changes of Pediatric Therapeutic Trials under the Best Pharmaceuticals for Children Act.

Authors:  Debbie Avant; Gerold T Wharton; Dianne Murphy
Journal:  J Pediatr       Date:  2017-10-10       Impact factor: 4.406

8.  Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015.

Authors:  Divya Hoon; Matthew T Taylor; Pooja Kapadia; Tobias Gerhard; Brian L Strom; Daniel B Horton
Journal:  Pediatrics       Date:  2019-09-16       Impact factor: 7.124

Review 9.  Pharmacokinetic studies in children: recommendations for practice and research.

Authors:  Charlotte I S Barker; Joseph F Standing; Lauren E Kelly; Lauren Hanly Faught; Allison C Needham; Michael J Rieder; Saskia N de Wildt; Martin Offringa
Journal:  Arch Dis Child       Date:  2018-04-19       Impact factor: 3.791

10.  Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.

Authors:  Peter S Azzopardi; Stephen J C Hearps; Kate L Francis; Elissa C Kennedy; Ali H Mokdad; Nicholas J Kassebaum; Stephen Lim; Caleb M S Irvine; Theo Vos; Alex D Brown; Surabhi Dogra; Stuart A Kinner; Natasha S Kaoma; Mariam Naguib; Nicola J Reavley; Jennifer Requejo; John S Santelli; Susan M Sawyer; Vegard Skirbekk; Marleen Temmerman; Jordan Tewhaiti-Smith; Joseph L Ward; Russell M Viner; George C Patton
Journal:  Lancet       Date:  2019-03-12       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.